Tag: MindImmune Therapeutics Inc.
Five Questions With: Stevin Zorn
Stevin Zorn is CEO, president and co-founder of MindImmune Therapeutics Inc., a drug discovery company launched to develop new treatments for Alzheimer’s and other central...
State of Innovation: R.I.’s ecosystem for entrepreneurs shows resilience
For the developers of Pointz, a navigation app geared toward safer routes for cyclists, Rhode Island offered a wealth of mentoring and networking opportunities,...
MindImmune Therapeutics closes $500K seed round led by Slater Fund
PROVIDENCE – MindImmune Therapeutics Inc., a pharmaceutical startup, closed its second seed round of $500,000 on Monday.
The round was led by a $250,000 investment...